Seelos Therapeutics, Inc. (SEELQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
May 28, 2025, 4:00 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2019 | FY 2016 | FY 2015 | FY 2014 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | 2016 - 2018 |
| Pharmaceutical Products | 2.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Products Growth | 487.47% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| License Fee | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| License Fee Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Royalty | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Royalty Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2019 | FY 2016 | FY 2015 | FY 2014 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | 2016 - 2018 |
| United States | 2.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 487.47% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Latin America | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Europe | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| France | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| France Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|